Literature DB >> 12557096

[Cricohyoidopexy (CHP) and Cricohyoidoepiglottopexy (CHEP). Indication, complications, functional und oncological results].

U Schröder1, M Jungehülsing, J P Klussmann, H E Eckel.   

Abstract

BACKGROUND: Subtotal laryngectomy with Cricohyoido(epiglotto)pexy (CHEP and CHP) is a commonly used surgical procedure in France, Italy and North America, but it is rarely carried out in Germany,where most laryngeal carcinomas staged T1-T3 are resected endoscopically or with total laryngectomy.
OBJECTIVE: To identify indications for the CHEP and CHP in a setting that uses endolaryngeal procedures as a standard approach to organ preserving surgery in laryngeal cancer patients. PATIENTS: Nineteen patients with primary (n=15) or recurrent (n=4), supra- or transglottic carcinoma or carcinoma of the anterior commissure staged (r)T1b-4N0-2cM0 were treated with subtotal laryngectomy with CHEP (with or without neck dissection/radiotherapy) between October 1997 and June 1999.
RESULTS: Undisturbed deglutition without aspiration and respiration without tracheotomy was achieved in 17/19 patients. Three patients showed temporary pneumonia from aspiration and two patients needed further treatment for endolaryngeal synechia. Three patients died of unrelated causes. Four patients were diagnosed with local recurrence: Two of them died from tumor, two patients had curative total laryngectomy as salvage surgery. Fourteen patients are living free of disease 24-40 months after therapy.
CONCLUSION: CHEP is a subtotal laryngectomy with increased postoperative morbidity, but good functional results. Assuming a scrupulous indication for the extended tumors the oncological results of the CHEP are satisfying, too.

Entities:  

Mesh:

Year:  2003        PMID: 12557096     DOI: 10.1007/s00106-002-0663-3

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  4 in total

1.  [The value of supracricoid partial laryngectomy in moderately advanced laryngeal cancer (T3-T4a)].

Authors:  U Schroeder; B Wollenberg; K L Bruchhage
Journal:  HNO       Date:  2015-11       Impact factor: 1.284

2. 

Authors:  M Jungehülsing; O Guntinas-Lichius; J P Klussmann; U Schröder
Journal:  HNO       Date:  2003-11       Impact factor: 1.284

3.  Analyses of functional and oncologic outcomes following supracricoid partial laryngectomy.

Authors:  Yan Wang; Xiaotian Li; Zimin Pan
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-31       Impact factor: 2.503

4.  [Surgical treatment options in laryngeal and hypopharyngeal cancer].

Authors:  Hans E Eckel; Ursula Schröder; Markus Jungehülsing; Orlando Guntinas-Lichius; Michael Markitz; Wolfgang Raunik
Journal:  Wien Med Wochenschr       Date:  2008
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.